Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Applied Biosciences Corp. (APPB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0021+0.0019 (+950.00%)
At close: 12:14PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/25/2021
Current
Market Cap (intraday) 5
2.82k
Enterprise Value 3
896.07k
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.00
Price/Book (mrq)
0.01
Enterprise Value/Revenue 3
1.04
Enterprise Value/EBITDA 7
-0.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1,640.40
52-Week Change 3-98.95%
S&P500 52-Week Change 326.87%
52 Week High 30.4500
52 Week Low 30.0001
50-Day Moving Average 30.0565
200-Day Moving Average 30.0751

Share Statistics

Avg Vol (3 month) 3209
Avg Vol (10 day) 3691
Shares Outstanding 514.1M
Implied Shares Outstanding 6N/A
Float 89.69M
% Held by Insiders 132.23%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 23, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Oct 23, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-311.94%

Management Effectiveness

Return on Assets (ttm)-64.15%
Return on Equity (ttm)-221.59%

Income Statement

Revenue (ttm)859.86k
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)-59.00%
Gross Profit (ttm)185.29k
EBITDA -2.52M
Net Income Avi to Common (ttm)-2.79M
Diluted EPS (ttm)-0.2030
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.27k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.15M
Total Debt/Equity (mrq)100.97
Current Ratio (mrq)0.11
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-933.9k
Levered Free Cash Flow (ttm)-89.62k
Advertisement
Advertisement